These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1616246)

  • 1. [Respiratory infections: germs sensitive to cefaclor].
    Ann Pediatr (Paris); 1992 May; 39(5):300. PubMed ID: 1616246
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy with cefaclor: analysis of infections in 189 French patients.
    Masbernard A; Salord JC
    Postgrad Med J; 1979; 55 Suppl 4():72-6. PubMed ID: 398484
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
    van Saene HK; Willems FT; Zweens J
    Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and microbiological evaluation of prodrug antibiotic SCE-2174. A new cephalosporin for oral use. A comparative open randomized study vs cefaclor in 50 patients with infections of the middle or lower respiratory tract].
    Girbino G; Giacobbe G; Fiorello G; Condoluci M; Molonia N
    Arch Monaldi Mal Torace; 1988; 43(6):533-43. PubMed ID: 3155015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cefaclor in the treatment of respiratory tract infections in children].
    Klech H; Stur O; Götz M
    Padiatr Padol; 1985; 20(3):297-306. PubMed ID: 4034220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection.
    Infection; 1991; 19(4):208-15. PubMed ID: 1917031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
    Iancu TC; Sinoff G
    Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphenazone sensitivity of some pathogens, and its effect in diseases of the upper respiratory tract.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1972; 13(3):225-30. PubMed ID: 4631517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. a. Changes in pathogens and chemotherapy after development of the third generation of cephalosporins].
    Saito A
    Nihon Rinsho; 1987 Mar; 45(3):554-8. PubMed ID: 3298732
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefaclor therapy for specific upper respiratory tract infections: pharyngitis, purulent rhinitis, laryngotracheitis.
    Carbon C
    Clin Ther; 1988; 11 Suppl A():48-53. PubMed ID: 3072085
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteriological aspects of infections of the upper respiratory tract.
    Kallings LO
    Scand J Infect Dis Suppl; 1983; 39():9-13. PubMed ID: 6580737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variations of microbial sensitivity in lower respiratory tract infections].
    Aguerre MM; Costa de Mello B
    Hoja Tisiol; 1971; 28(1-2):41-76. PubMed ID: 5173683
    [No Abstract]   [Full Text] [Related]  

  • 14. Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.
    Preston DA
    Clin Ther; 1993; 15(1):88-96. PubMed ID: 8458058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of inhibitory index in the comparison of 4 oral beta-lactams against germs responsible of bronchopulmonary infections in pediatrics].
    Lambert-Zechovsky N; Mariani-Kurkdjian P; Bingen E; Lemer G; Guedj D
    Therapie; 1988; 43 Suppl 4():351-3. PubMed ID: 3222775
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distribution and drug resistance of the isolated bacteria from children with acute respiratory infection].
    Guo J; Cui ZZ; Huang Y; Yu AM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):579-82. PubMed ID: 18947473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefaclor in the treatment of lower respiratory tract infections: a review.
    Brown RB
    Clin Ther; 1988; 11 Suppl A():54-65. PubMed ID: 3072087
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefaclor revisited.
    Meyers BR
    Clin Ther; 2000 Feb; 22(2):154-66. PubMed ID: 10743978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterobacteria and respiratory tract disease.
    Dusaj M; Gupta NP
    Indian J Chest Dis; 1968 Apr; 10(2):11-6. PubMed ID: 5761029
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical advances in oral antibiotic therapy. Summary and closing remarks.
    Neu HC
    Postgrad Med J; 1979; 55 Suppl 4():100-1. PubMed ID: 548938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.